| Date Filed | Type | Description |
| 03/21/2023 |
3
| Pimblett Emily (Chief Accounting Officer) has filed a Form 3 on Eliem Therapeutics, Inc. |
| 03/14/2023 |
4
| Morisset Valerie (EVP, R&D and CSO) has filed a Form 4 on Eliem Therapeutics, Inc.|
Txns:
| Exercised 255,219 options to buy
@ $0.002, valued at
$510.4
Exercised 61,191 options to buy
@ $0.0002, valued at
$12.2 |
|
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2022 |
4
| Tate Simon (Director) has filed a Form 4 on Eliem Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $3.46, valued at
$34.6k
|
|
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2022 |
4
| Rosenberg Adam Joseph (Director) has filed a Form 4 on Eliem Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $3.46, valued at
$34.6k
|
|
| 06/01/2022 |
4
| Levin Andrew David (Director) has filed a Form 4 on Eliem Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $3.46, valued at
$34.6k
|
|
| 06/01/2022 |
4
| Dunn Judith (Director) has filed a Form 4 on Eliem Therapeutics, Inc.|
Txns:
| Granted 10,000 options to buy
@ $3.46, valued at
$34.6k
|
|
| 01/31/2022 |
4
| Lavelle Erin (COO & CFO) has filed a Form 4 on Eliem Therapeutics, Inc.|
Txns:
| Granted 170,000 options to buy
@ $8.21, valued at
$1.4M
|
|
| 01/31/2022 |
4
| Azelby Robert (President & CEO) has filed a Form 4 on Eliem Therapeutics, Inc.|
Txns:
| Granted 500,000 options to buy
@ $8.21, valued at
$4.1M
|
|
| 01/31/2022 |
4
| Morisset Valerie (EVP, R&D and CSO) has filed a Form 4 on Eliem Therapeutics, Inc.|
Txns:
| Granted 170,000 options to buy
@ $8.21, valued at
$1.4M
|
|
| 01/31/2022 |
4
| Bucher James B (EVP and General Counsel) has filed a Form 4 on Eliem Therapeutics, Inc.|
Txns:
| Granted 95,000 options to buy
@ $8.21, valued at
$780k
|
|
| 08/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/11/2021 |
4
| Rosenberg Adam Joseph (Director) has filed a Form 4 on Eliem Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $12.5, valued at
$250k
|
|
| 08/11/2021 |
4
| Tate Simon (Director) has filed a Form 4 on Eliem Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $12.5, valued at
$250k
|
|
| 08/11/2021 |
4
| Levin Andrew David (Director) has filed a Form 4 on Eliem Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $12.5, valued at
$250k
|
|
| 08/09/2021 |
3
| AI ETI LLC (10% Owner) has filed a Form 3 on Eliem Therapeutics, Inc. |
| 08/09/2021 |
3
| Dunn Judith (Director) has filed a Form 3 on Eliem Therapeutics, Inc. |
| 08/09/2021 |
3
| PATTERSON LEONE D (Director) has filed a Form 3 on Eliem Therapeutics, Inc. |
| 08/09/2021 |
3
| Ratcliffe Liam (Director) has filed a Form 3 on Eliem Therapeutics, Inc. |
| 08/09/2021 |
3
| Rosenberg Adam Joseph (Director) has filed a Form 3 on Eliem Therapeutics, Inc. |
| 08/09/2021 |
3
| Tate Simon (Director) has filed a Form 3 on Eliem Therapeutics, Inc. |
| 08/09/2021 |
3
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 3 on Eliem Therapeutics, Inc. |
| 08/09/2021 |
3
| Levin Andrew David (Director) has filed a Form 3 on Eliem Therapeutics, Inc. |
| 08/09/2021 |
3
| Bucher James B (EVP and General Counsel) has filed a Form 3 on Eliem Therapeutics, Inc. |
| 08/09/2021 |
3
| Lavelle Erin (COO & CFO) has filed a Form 3 on Eliem Therapeutics, Inc. |
|